natgillin/translations-raw huggingface dataset:
Vardenafil AUC and Cmax in elderly patients (65 years or over) taking vardenafil orodispersible tablets were increased by 31 to 39% and 16 to 21%, respectively, in comparison to patients aged 45 years and below. 
AUC and Cmax vardenafila u starijih bolesnika (u dobi od 65 ili više godina) koji su uzimali vardenafil raspadljive tablete za usta bili su povećani za 31 do 39% odnosno 16 do 21% u usporedbi s onima u bolesnika u dobi do 45 godina.
Levitra is contraindicated in patients who have loss of vision in one eye because of non-arteritic anterior ischemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous phosphodiesterase 5 (PDE5) inhibitor exposure (see section 4.4). 
Levitra je kontraindicirana u bolesnika koji su izgubili vid na jedno oko zbog nearteritičke prednje ishemijske optičke neuropatije (NAION), bez obzira na to je li ta epizoda bila povezana s prethodnom izloženosti inhibitoru fosfodiesteraze tipa 5 (PDE5) (vidjeti dio 4.4).
After oral dosing of vardenafil AUC and Cmax increase almost dose proportionally over the recommended dose range (5 - 20 mg). 
Nakon peroralne primjene, AUC i Cmax vardenafila povećavaju se gotovo proporcionalno primijenjenoj dozi unutar raspona preporučenih doza (5-20 mg).
In general, the incidence of adverse reactions (especially “dizziness”) has been shown to be slightly higher in patients with a history of hypertension. 
Općenito se pokazalo da je incidencija nuspojava (osobito “omaglica”) blago viša u bolesnika s hipertenzijom u anamnezi.
After oral administration, vardenafil is excreted as metabolites predominantly in the faeces (approximately 91-95% of the administered dose) and to a lesser extent in the urine (approximately 2-6% of the administered dose). 
Nakon peroralne primjene, vardenafil se izlučuje kao metabolit pretežno u stolici (približno 91-95% primijenjene doze) i u manjoj mjeri u mokraći (približno 2-6% primijenjene doze).
In vardenafil film-coated tablets, vardenafil is rapidly absorbed with maximum observed plasma concentrations reached in some men as early as 15 minutes after oral administration. 
Vardenafil se iz vardenafil filmom obloženih tableta brzo apsorbira i postiže maksimalne koncentracije u plazmi kod nekih muškaraca već 15 minuta nakon peroralne primjene.
Stepwise increase in alpha-blocker dose may be associated with further lowering of blood pressure in patients taking vardenafil. 
Postupno povećanje doze alfa-blokatora može biti povezano s dodatnim sniženjem krvnog tlaka u bolesnika koji uzimaju vardenafil.
In the predefined subgroups 57% (elderly patients), 56% (patients with history of diabetes mellitus), 59% (patients with history of dyslipidemia) and 60% (patients with history of hypertension) of all reported attempts with vardenafil 10 mg orodispersible tablets were successful in terms of maintenance of erection. 
U unaprijed definiranim podskupinama, 57% (stariji bolesnici), 56% (bolesnici sa šećernom bolešću), 59% (bolesnici s dislipidemijom) i 60% (bolesnici s hipertenzijom u anamnezi) svih zabilježenih pokušaja uz vardenafil 10 mg raspadljive tablete za usta bilo je uspješno u smislu održavanja erekcije.
2 film-coated tablets 4 film-coated tablets 8 film-coated tablets 12 film-coated tablets 20 film-coated tablets 
2 filmom obložene tablete 4 filmom obložene tablete 8 filmom obloženih tableta 12 filmom obloženih tableta 20 filmom obloženih tableta
Visual defects and cases of non-arteritic ischemic optic neuropathy (NAION) have been reported in connection with the intake of Levitra and other PDE5 inhibitors. 
Oslabljen vid i slučajevi nearteritičke ishemijske optičke neuropatije (NAION) zabilježeni su u vezi s uzimanjem lijeka Levitra i drugih inhibitora PDE5.
See section 2 “Levitra 10 mg orodispersible tablets contain Aspartame and Sorbitol”. 
Vidjeti dio 2 „Levitra 10 mg raspadljive tablete za usta sadrže aspartam i sorbitol“.
If you are allergic to vardenafil or any of the other ingredients of this medicine (listed in section 6). 
Nemojte uzimati lijek Levitra - ako ste alergični na vardenafil ili neki drugi sastojak ovog lijeka (naveden u dijelu 6).
Levitra is not intended for use by children or adolescents under 18. 
Djeca i adolescenti Levitra nije namijenjena za primjenu u djece i adolescenata mlađih od 18 godina.
Levitra orodispersible tablets must be taken without liquid and immediately upon release from the blister. 
Levitra raspadljive tablete za usta moraju se uzeti bez tekućine i odmah nakon vađenja iz blistera.
In men older than 75 years the concomitant use of vardenafil with itraconazole or ketoconazole is contraindicated (see section 4.3). 
U muškaraca starijih od 75 godina, istodobna primjena vardenafila s itrakonazolom ili ketokonazolom je kontraindicirana (vidjeti dio 4.3).
On average elderly males taking vardenafil film-coated tablets had a 52% higher AUC, and a 34% higher Cmax than younger males (see section 4.2). 
U prosjeku, stariji muškarci koji su uzimali vardenafil filmom obložene tablete imali su 52% veći AUC i 34% veći Cmax nego mlađi muškarci (vidjeti dio 4.2).
The adverse reactions reported with Levitra film-coated tablets or 10 mg orodispersible tablets in clinical trials were generally transient and mild to moderate in nature. 
Nuspojave zabilježene uz Levitra filmom obložene tablete ili 10 mg raspadljive tablete za usta u kliničkim su ispitivanjima bile općenito prolazne i blage do umjerene naravi.
Among subjects treated with terazosin, hypotension was observed more frequently when vardenafil and terazosin were given simultaneously than when the dosing was separated by a time interval of 6 hours. 
Kod ispitanika liječenih terazosinom hipotenzija je bila češće primijećena kad su se vardenafil i terazosin primjenjivali istodobno nego kad su se primjenjivali u razmaku od 6 sati.
If you suffer from irregular heart beat (cardiac arrhythmia) or inherited heart diseases affecting your electrocardiogram. 
- ako bolujete od nepravilnog rada srca (srčane aritmije) ili nasljedne srčane bolesti koja utječe na
The distribution of patients in the predefined subgroups was covering elderly patients (51%), patients with history of diabetes mellitus (29%), dyslipidemia (39%) and hypertension (40%). 
Raspodjelom bolesnika u prethodno definirane podskupine pokriveni su stariji bolesnici (51%), bolesnici sa šećernom bolešću (29%), dislipidemijom (39%) i hipertenzijom (40%).
In pooled data from the major efficacy trials, the proportion of patients experiencing successful penetration on vardenafil were as follows: psychogenic erectile dysfunction (77-87%), mixed erectile dysfunction (69-83%), organic erectile dysfunction (64-75%), elderly (52-75%), ischaemic heart disease (70-73%), hyperlipidaemia (62-73%), chronic pulmonary disease (74-78%), depression (59-69%), and patients concomitantly treated with antihypertensives (62-73%). 
U objedinjenim podacima iz velikih ispitivanja djelotvornosti, udio bolesnika koji su imali uspješnu penetraciju uz vardenafil bili su sljedeći: psihogena erektilna disfunkcija (77-87%), miješana erektilna disfunkcija (69-83%), organska erektilna disfunkcija (64-75%), stariji (52-75%), ishemijska bolest srca (70-73%), hiperlipidemija (62-73%), kronična bolest pluća (74-78%), depresija (59-69%) i bolesnici istodobno liječeni antihipertenzivima (62-73%).
The vardenafil results showed an increase in QTc (Fridericia) of 8 msec (90% CI: 6-9) and 10 msec (90% CI: 8-11) at 10 and 80 mg doses compared to placebo and an increase in QTci of 4 msec (90% CI: 3-6) and 6 msec (90% CI: 4-7) at 10 and 80 mg doses compared to placebo, at one hour post-dose. 
Rezultati vardenafila pokazali su produženje QTc (Fridericia) za 8 ms (90% CI: 6-9) i 10 ms (90% CI: 8-11) uz doze od 10 i 80 mg u usporedbi s placebom i produženje QTci (individualno korigirani QT) za 4 ms (90% CI: 3-6) i 6 ms (90% CI: 4-7) uz doze od 10 i 80 mg u usporedbi s placebom jedan sat nakon primjene doze.
- If you are taking medicines containing nitrates, such as glycerol trinitrate for angina, or nitric oxide donors, such as amyl nitrite. 
- ako uzimate lijekove koji sadrže nitrate, kao što je glicerol trinitrat za anginu, ili sredstva koja otpuštaju dušikov oksid, kao što je amil nitrat.
Medicinal products for the treatment of erectile dysfunction should be used with caution in patients with anatomical deformation of the penis (such as angulation, cavernosal fibrosis or Peyronie's disease), or in patients who have conditions which may predispose them to priapism (such as sickle cell anaemia, multiple myeloma or leukaemia). 
Lijekove za liječenje erektilne disfunkcije treba primjenjivati s oprezom u bolesnika s anatomskom deformacijom penisa (kao što su angulacija, kavernozna fibroza ili Peyronieva bolest) i u bolesnika sa stanjima zbog kojih su skloniji prijapizmu (kao što su anemija srpastih stanica, multipli mijelom ili leukemija).
When vardenafil film-coated tablets are taken with a high fat meal (containing 57% fat), the rate of absorption is reduced, with an increase in the median tmax of 1 hour and a mean reduction in Cmax of 20%. 
Kad se vardenafil filmom obložene tablete uzmu uz obrok bogat mastima (koji sadrži 57% masti), brzina apsorpcije se smanjuje, uz povećanje medijana tmax za 1 sat i prosječno smanjenje Cmax za 20%.
Medicinal products for the treatment of erectile dysfunction should generally not be used in men for whom sexual activity is inadvisable (e.g. patients with severe cardiovascular disorders such as unstable angina or severe cardiac failure [New York Heart Association III or IV]). 
Lijekovi za liječenje erektilne disfunkcije općenito se ne bi smjeli primjenjivati u muškaraca kojima se inače ne savjetuje spolna aktivnost (npr. bolesnici s teškim kardiovaskularnim poremećajima kao što su nestabilna angina ili teško zatajenje srca [klasa III ili IV prema New York Heart Association]).
No significant interactions were shown when warfarin (25 mg), which is metabolised by CYP2C9, or digoxin (0.375 mg) was co-administered with vardenafil (20 mg film-coated tablets). 
Nije se pokazalo da postoje značaje interakcije kad su se varfarin (25 mg), kojeg metabolizira CYP2C9, ili digoksin (0,375 mg) primjenjivali istodobno s vardenafilom (20 mg filmom obložene tablete).
Take a Levitra tablet about 25 to 60 minutes before sexual activity. 
Uzmite tabletu Levitra oko 25 do 60 minuta prije spolnog odnosa.
Increase in intraocular pressure Lacrimation increased 
fotofobija povećan intraokularni tlak,
• When vardenafil 5 mg (film-coated tablets) was given simultaneously with terazosin 5 or 10 mg, one of 21 patients experienced symptomatic postural hypotension. 
• Kad se vardenafil 5 mg (filmom obložene tablete) davao istodobno s terazosinom od 5 ili 10 mg, jedan od 21 bolesnika razvio je simptomatsku posturalnu hipotenziju.
Based on measurements of vardenafil in semen of healthy subjects 90 minutes after dosing, not more than 0.00012% of the administered dose may appear in the semen of patients. 
Na temelju mjerenja vardenafila u sjemenu zdravih ispitanika 90 minuta nakon uzimanja doze, u spermi bolesnika može biti prisutno najviše 0,00012% primijenjene doze.
Hepatic clearance of vardenafil in healthy elderly volunteers (65 years and over) was reduced as compared to healthy younger volunteers (18 - 45 years). 
Jetreni klirens vardenafila u zdravih starijih ispitanika (u dobi od 65 ili više godina) bio je smanjen u usporedbi s onim u mlađih zdravih ispitanika (u dobi od 18-45 godina).
SC Bayer SRL. 
România SC Bayer SRL.
Vardenafil potently enhances the effect of endogenous nitric oxide in the corpus cavernosum by inhibiting PDE5. 
Vardenafil izrazito pojačava učinak endogenog dušikovog oksida u kavernoznom tijelu tako što inhibira PDE5.
- If you have an illness that can cause erections which won't go away (priapism). 
- ako imate bolest koja može prouzročiti neprekidnu erekciju (prijapizam).
Cases of sudden death, fast or altered heart beat, heart attack, chest pain, and trouble in cerebral circulation (including temporarily decreased blood flow to parts of the brain and bleeding in the brain) have been reported in men taking vardenafil. 
Zabilježeni su slučajevi iznenadne smrti, brzih ili izmijenjenih otkucaja srca, srčanog udara, boli u prsnom košu i problema s cirkulacijom u mozgu (uključujući privremeno smanjenje protoka krvi u određene dijelove mozga i krvarenje u mozgu) u muškaraca koji su uzimali vardenafil.
Levitra 10 mg orodispersible tablets are not bioequivalent to Levitra 10 mg film-coated tablets (see section 5.1). 
Levitra 10 mg raspadljive tablete za usta nisu bioekvivalentne Levitra 10 mg filmom obloženim tabletama (vidjeti dio 5.1).
Men who take too much Levitra may experience more side effects or may get severe back pain. 
Ako uzmete više lijeka Levitra nego što ste trebali Muškarci koji uzmu previše lijeka Levitra mogu razviti više nuspojava ili dobiti jaku bol u leđima.
The ability to maintain the erection (SEP 3) in this broad ED population was given as 53% (5 mg), 63% (10 mg) and 65% (20 mg) compared to 29% on placebo. 
Sposobnost održavanja erekcije (SEP 3) u ovoj širokoj populaciji s ED bila je 53% (5 mg), 63% (10 mg) i 65% (20 mg) u usporedbi s 29% bolesnika koji su primali placebo.
Based on tolerability and efficacy the dose may be increased to 10 mg and 20 mg. 
Na temelju podnošljivosti i djelotvornosti, doza se može povećati na 10 mg i 20 mg.
Both vardenafil and sildenafil showed an increase of Fridericia QTc effect of 4 msec (vardenafil) and 5 msec (sildenafil) when compared to either drug alone. 
I vardenafil i sildenafil pokazali su produljenje QTc (Fridericia) učinka za 4 ms (vardenafil) i 5 ms (sildenafil) u usporedbi samo s jednim ili samo s drugim lijekom.
As this may be relevant for all patients exposed to vardenafil the patient should be advised that in the case of sudden visual defect, he should stop taking Levitra orodispersible tablets and consult immediately a physician (see section 4.3). 
S obzirom na to da navedeno može biti relevantno za sve bolesnike izložene vardenafilu, bolesnika treba savjetovati da u slučaju iznenadnog slabljenja vida prestane uzimati Levitra raspadljive tablete za usta i odmah potraži savjet liječnika (vidjeti dio 4.3).
As this may be relevant for all patients exposed to vardenafil the patient should be advised that in the case of sudden visual defect, he should stop taking Levitra and consult immediately a physician (see section 4.3). 
S obzirom na to da navedeno može biti relevantno za sve bolesnike izložene vardenafilu, bolesnika treba savjetovati da u slučaju iznenadnog slabljenja vida prestane uzimati lijek Levitra i odmah potraži savjet liječnika (vidjeti dio 4.3).
Therefore, inhibitors of these isoenzymes may reduce vardenafil clearance. 
Stoga inhibitori ovih izoenzima mogu smanjiti klirens vardenafila.
There was no consistent difference in mean Cmax between orodispersible tablets and film-coated tablets. 
Nije bilo dosljedne razlike u prosječnoj Cmax između raspadljivih tableta za usta i filmom obloženih tableta.
No clinical trials in CNS diseases (except spinal cord injury), patients with severe renal or hepatic impairment, pelvic surgery (except nerve-sparing prostatectomy) or trauma or radiotherapy and hypoactive sexual desire or penile anatomic deformities have been performed. 
Nisu provedena klinička ispitivanja u bolesnika s bolestima središnjeg živčanog sustava (osim ozljede leđne moždine), teškim oštećenjem bubrega ili jetre, operacijom u zdjelici (osim prostatektomije s poštedom živaca) ili traumom ili radioterapijom i smanjenom spolnom željom ili anatomskim deformacijama penisa.
The mean maximum decreases in supine systolic blood pressure following 20 mg and 40 mg vardenafil were - 6.9 mmHg under 20 mg and - 4.3 mmHg under 40 mg of vardenafil, when compared to placebo. 
Najveće prosječno smanjenje sistoličkog krvnog tlaka u ležećem položaju nakon 20 mg i 40 mg vardenafila bilo je - 6,9 mm Hg uz 20 mg i - 4,3 mm Hg uz 40 mg vardenafila, u usporedbi s placebom.
Levitra 10 mg orodispersible tablets contain Aspartame and Sorbitol. 
Levitra 10 mg raspadljive tablete za usta sadrže aspartam i sorbitol.
Concomitant use of vardenafil with the potent CYP3A4 inhibitors ketoconazole and itraconazole (oral form) is contraindicated in men older than 75 years. 
Istodobna primjena vardenafila s jakim inhibitorima CYP3A4 ketokonazolom i itrakonazolom (oralni oblik) kontraindicirana je u muškaraca starijih od 75 godina.
Based on efficacy and tolerability the dose may be increased to 20 mg or decreased to 5 mg. 
Na temelju djelotvornosti i podnošljivosti doza se može povećati na 20 mg ili smanjiti na 5 mg.
Levitra orodispersible tablets can be taken with or without food. 
Levitra raspadljive tablete za usta mogu se uzimati s hranom ili bez nje.
Levitra 10 mg orodispersible tablets are round and white. 
Levitra 10 mg raspadljive tablete za usta okrugle su i bijele.
- The active substance is vardenafil. 
Što Levitra sadrži - Djelatna tvar je vardenafil.
The pharmacokinetics of vardenafil (20 mg) was not affected by co-administration with the H2-antagonist ranitidine (150 mg twice daily), digoxin, warfarin, glibenclamide, alcohol (mean maximum blood alcohol level of 73 mg/dl) or single doses of antacid (magnesium hydroxide/aluminium hydroxide). 
Na farmakokinetiku vardenafila (20 mg) nije utjecala istodobna primjena H2-antagonista ranitidina (150 mg dvaput na dan), digoksina, varfarina, glibenklamida, alkohola (srednja vrijednost maksimalne razine alkohola u krvi 73 mg/dl) niti jednokratne doze antacida (magnezijev hidroksid/aluminijev hidroksid).
In volunteers with severe renal impairment (creatinine clearance <30 ml/min) the mean AUC was increased by 21% and the mean Cmax decreased by 23%, compared to volunteers with no renal impairment. 
U dobrovoljaca s teškim oštećenjem funkcije bubrega (klirens kreatinina < 30 ml/min) srednja vrijednost AUC-a bila je povećana za 21%, a srednja vrijednost Cmax smanjena za 23% u usporedbi s dobrovoljcima bez oštećenja bubrežne funkcije.
At a dose of 20 mg Levitra film-coated tablets, elderly (≥ 65 years old) patients had higher frequencies of headaches (16.2% versus 11.8%) and dizziness (3.7% versus 0.7%) than younger patients (<65 years old). 
Uz Levitra filmom obložene tablete od 20 mg, stariji (u dobi od ≥ 65 godina) bolesnici imali su veću učestalost glavobolja (16,2% nasuprot 11,8%) i omaglice (3,7% nasuprot 0,7%) nego mlađi bolesnici (u dobi od < 65 godina).
In a penile plesthysmography (RigiScan) study, vardenafil 20 mg produced erections considered sufficient for penetration (60% rigidity by RigiScan) in some men as early as 15 minutes after dosing. 
Ispitivanje s pletizmografijom penisa (RigiScan) pokazalo je da vardenafil od 20 mg u nekih muškaraca izaziva erekciju dostatnu za penetraciju (60% ukrućenja po RigiScan-u) već 15 minuta nakon doziranja.
The response rates for the ability to obtain and maintain an erection were 76% and 59% on vardenafil compared to 41% and 22% on placebo for patients who completed three months treatment which were clinically and statistically significant (p<0.001). 
Stope odgovora za sposobnost postizanja odnosno održavanja erekcije bile su 76% odnosno 59% uz vardenafil u usporedbi s 41% odnosno 22% uz placebo u bolesnika koji su dovršili tri mjeseca liječenja, a što je bilo klinički i statistički značajno (p < 0,001).
1 x 1 orodispersible tablet 2 x 1 orodispersible tablets 4 x 1 orodispersible tablets 8 x 1 orodispersible tablets 
1 x 1 raspadljiva tableta za usta 2 x 1 raspadljive tablete za usta 4 x 1 raspadljive tablete za usta 8 x 1 raspadljivih tableta za usta
Although specific interaction studies were not conducted for all medicinal products, population pharmacokinetic analysis showed no effect on vardenafil pharmacokinetics of the following concomitant medicinal products: acetylsalicylic acid, ACE-inhibitors, beta-blockers, weak CYP3A4 inhibitors, diuretics and medicinal products for the treatment of diabetes (sulfonylureas and metformin). 
Premda nisu provedena zasebna ispitivanja interakcija sa svim lijekovima, analiza populacijske farmakokinetike pokazala je da istodobna primjena sljedećih lijekova ne utječe na farmakokinetiku vardenafila: acetilsalicilna kiselina, ACE inhibitori, beta blokatori, slabi inhibitori CYP3A4, diuretici i lijekovi za liječenje šećerne bolesti (derivati sulfonilureje i metformin).
Talk to a doctor without taking 
Razgovarajte s liječnikom prije uzimanja lijeka
No potentiation of the blood pressure lowering effect of sublingual nitroglycerin (0.4 mg) was observed when vardenafil (10 mg) was given at varying time intervals (1 h to 24 h) prior to the dose of nitroglycerin in a study in 18 healthy male subjects. 
Nije bio primijećen pojačani učinak sublingvalnog nitroglicerina (0,4 mg) na sniženje krvnog tlaka kad se vardenafil (10 mg) davao u različitim vremenskim razmacima (1 h do 24 h) prije doze nitroglicerina u ispitivanju u 18 zdravih muških ispitanika.
Medicinal products that may prolong QTc interval, including vardenafil, are best avoided in patients with relevant risk factors, for example, hypokalaemia, congenital QT prolongation, concomitant administration of antiarrhythmic medicinal products in Class 1A (e.g. quinidine, procainamide), or Class III (e.g. amiodarone, sotalol). 
Lijekove koji mogu produljiti QTc interval, uključujući vardenafil, najbolje je izbjegavati u bolesnika s važnim čimbenicima rizika, na primjer, hipokalemijom, kongenitalnim produljenjem QT intervala, istodobnom primjenom antiaritmika skupine 1A (npr. kinidin, prokainamid) ili skupine III (npr., amiodaron, sotalol).
The relative bioavailability of glibenclamide (3.5 mg) was not affected when co-administered with vardenafil (20 mg). 
Relativna bioraspoloživost glibenklamida (3,5 mg) se nije promijenila kad se primjenjivao istodobno s vardenafilom (20 mg).
Tolerability of the maximum dose of 20 mg may be lower in elderly patients (≥65 years old) (see sections 4.2 and 4.8). 
Podnošljivost maksimalne doze od 20 mg može biti slabija u starijih bolesnika (u dobi od ≥ 65 godina) (vidjeti dijelove 4.2 i 4.8).
Patients with left ventricular outflow obstruction, e.g., aortic stenosis and idiopathic hypertrophic subaortic stenosis, can be sensitive to the action of vasodilators including Type 5 phosphodiesterase inhibitors. 
Bolesnici s opstruktivnim smetnjama izlaznog trakta lijeve klijetke, npr., aortalnom stenozom i idiopatskom hipertrofičnom subaortalnom stenozom, mogu biti osjetljivi na djelovanje vazodilatatora uključujući inhibitore fosfodiesteraze tipa 5.
(≥1/1,000 to 
(≥ 1/1000 i
Vardenafil 10 mg orodispersible tablets must be taken without liquid. 
Vardenafil 10 mg raspadljive tablete za usta moraju se uzimati bez tekućine.
Bioequivalence studies have shown that vardenafil 10 mg orodispersible tablet is not bioequivalent to vardenafil 10 mg film-coated tablets. 
Ispitivanja bioekvivalencije pokazala su da vardenafil 10 mg raspadljive tablete za usta nisu bioekvivalentne vardenafil 10 mg filmom obloženim tabletama.
Further information on clinical trials with vardenafil 10 mg orodispersible tablets Efficacy and safety of vardenafil 10 mg orodispersible tablets were separately demonstrated in a broad population in two studies including 701 randomized erectile dysfunction patients who were treated up to 12 weeks. 
Dodatne informacije o kliničkim ispitivanjima vardenafil 10 mg raspadljivih tableta za usta Djelotvornost i sigurnost primjene vardenafil 10 mg raspadljivih tableta za usta zasebno su se provjerile u široj populaciji u dva ispitivanja koja su uključila 701 randomiziranog bolesnika s erektilnom disfunkcijom koji su se liječili do 12 tjedana.
In single dose volunteer studies, doses up to and including 80 mg vardenafil (film-coated tablets) per day were tolerated without exhibiting serious adverse reactions. 
U ispitivanjima jednokratne doze u zdravih dobrovoljaca, doze do uključivo 80 mg vardenafila (filmom obložene tablete) na dan podnosile su se bez vidljivih ozbiljnih nuspojava.